Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SkinBioTherapeutics ( (GB:SBTX) ) has shared an update.
SkinBioTherapeutics PLC, an entity in the biotechnology sector, has been involved in a change concerning its voting rights. Optibiotix Health PLC, a stakeholder based in York, UK, has adjusted its holdings in SkinBioTherapeutics, reducing its voting rights from 10.92% to 9.58%, which corresponds to a decrease in the total number of voting rights from 24,940,639 to 21,884,389.
More about SkinBioTherapeutics
YTD Price Performance: 13.77%
Average Trading Volume: 1,534,304
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £39.63M
See more insights into SBTX stock on TipRanks’ Stock Analysis page.